Tom Masterson

Tom brings over 25 years of capital markets and investment banking expertise to Allele.​ Since 2012, he has focused on the life sciences sector and has specialized in raising equity and debt for public and private biopharma, specialty pharma, medtech, and medical device companies. Tom has extensive relationships with Family Offices, Private Equity, Venture Capital, Royalty, and Specialty Hedge Funds. Prior to that, Tom was focused on SPACs (Special Purpose Acquisition Companies) and specialized in the institutional placement of the IPOs and daily trading of SPACs. Tom advised management teams and transitioned institutional shareholder bases during the private to public company merger process. Prior to that, Tom was a financial advisor for independent and bulge bracket investment firms, including National Financial Partners, Raymond James, Lehman Brothers, and Paine Webber.​

​Tom is a graduate of the Isenberg School of Management at The University of Massachusetts, Amherst. Tom also serves on Wilmington Capital Securities’ Life Sciences Investment Banking Division and holds FINRA series 7, 79, and 63 licenses.​